Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Urologia Internationalis|April 14, 2016
High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based PolychemotherapyL Solari, M Krönig, G Ihorst, et al.
British Journal of Haematology|November 20, 2002
Telomere maintenance in human B lymphocytesUwe M Martens, Volker Brass, Lucie Sedlacek, et al.
Human Pathology|February 5, 2011
The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemiaKonrad Aumann, Silke Lassmann, Anja Schöpflin, et al.
Clinical Lung Cancer|December 3, 2014
An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancerCornelius F Waller, Ihor Vynnychenko, Igor Bondarenko, et al.
Blood|April 23, 2005
Efficient marking of human cells with rapid but transient repopulating activity in autografted recipientsHanno Glimm, Manfred Schmidt, Marlene Fischer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 8, 2010
The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trialMartin Sebastian, Martin Reck, Cornelius F Waller, et al.
British Journal of Clinical Pharmacology|June 22, 2018
A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumabCornelius F Waller, Apinya Vutikullird, Tracey E Lawrence, et al.
Nature Communications|May 18, 2024
Cerebral microstructural alterations in Post-COVID-condition are related to cognitive impairment, olfactory dysfunction and fatigueJonas A Hosp, Marco Reisert, Andrea Dressing, et al.
Acta Haematologica|October 17, 2023
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid LeukemiaSusanne Saussele, Paul La Rosée, Alexander Kiani, et al.
Nature Communications|April 10, 2021
IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individualsMichal A Stanczak, David E Sanin, Petya Apostolova, et al.
Pageof 9